|
US6440421B1
(en)
|
1996-04-18 |
2002-08-27 |
Auchkland Uniservices Limited |
Treatment of bone disorders with adrenomedullin or adrenomedullin agonists
|
|
US5888963A
(en)
*
|
1996-04-18 |
1999-03-30 |
Auckland Uniservices Limited |
Treatment of bone disorders with adrenomedullin
|
|
WO1999016406A2
(en)
*
|
1997-09-26 |
1999-04-08 |
Auckland Uniservices Limited |
Therapeutic method
|
|
WO2001018550A2
(en)
*
|
1999-09-10 |
2001-03-15 |
The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Determination of adrenomedullin-binding proteins
|
|
US20040047988A1
(en)
*
|
2000-11-17 |
2004-03-11 |
Jin-Kyu Lee |
Poly(methylsilsesquioxane) copolymers and preparation method thereof
|
|
FR2821080B1
(fr)
*
|
2001-02-20 |
2003-12-19 |
Sanofi Synthelabo |
Anticorps specifique de l'adrenomedulline humaine, composition pharmaceutique le contenant, ses applications therapeutiques
|
|
US20110087312A1
(en)
*
|
2001-03-02 |
2011-04-14 |
Erchonia Corporatin |
Method for Treatment of Diabetes and Prediabetes with Low-Level Laser Therapy
|
|
JP2005508838A
(ja)
|
2001-03-23 |
2005-04-07 |
アフトン コーポレーション |
膵癌の組合せ治療
|
|
US20090191232A1
(en)
|
2001-05-04 |
2009-07-30 |
Gevas Philip C |
Combination therapy for the treatment of tumors
|
|
JPWO2003078460A1
(ja)
*
|
2002-03-19 |
2005-07-14 |
株式会社オンコレックス |
ペプチド、該ペプチドを含有する医薬組成物及び癌治療用医薬組成物
|
|
US20040127445A1
(en)
*
|
2002-08-28 |
2004-07-01 |
Chondrogene Limited |
Beta-2 microglobulin (B2M) and B2M related gene products for the regulation of osteoarthritis pathogenesis and chondrocyte proliferation
|
|
CA2500405A1
(en)
*
|
2002-09-30 |
2004-04-15 |
Oncotherapy Science, Inc. |
Genes and polypeptides relating to human myeloid leukemia
|
|
US20040121375A1
(en)
*
|
2002-09-30 |
2004-06-24 |
Bayer Pharmaceuticals Corporation |
Methods for prediction and prognosis of cancer, and monitoring cancer therapy
|
|
US7364719B2
(en)
|
2002-10-04 |
2008-04-29 |
The United States Of America As Represented By The Department Of Health And Human Services |
Vasoregulating compounds and methods of their use
|
|
EP1575511A4
(en)
*
|
2002-11-07 |
2006-06-28 |
Us Gov Health & Human Serv |
NEW TARGET FOR ANGIOGENESIS AND ANTI-ANGIOGENESIS THERAPY
|
|
WO2004088326A2
(en)
*
|
2003-03-28 |
2004-10-14 |
Aphton Corporation |
Gastrin hormone immunoassays
|
|
US7228658B2
(en)
|
2003-08-27 |
2007-06-12 |
Weyerhaeuser Company |
Method of attaching an end seal to manufactured seeds
|
|
AU2004273057C1
(en)
*
|
2003-09-08 |
2011-06-30 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Non-peptide agonists and antagonists of adrenomedullin and gastrin releasing peptide
|
|
US8691575B2
(en)
*
|
2003-09-30 |
2014-04-08 |
Weyerhaeuser Nr Company |
General method of classifying plant embryos using a generalized Lorenz-Bayes classifier
|
|
CA2484533C
(en)
*
|
2003-11-25 |
2008-12-02 |
Weyerhaeuser Company |
Systems and method of embryo delivery for manufactured seeds
|
|
US20050108935A1
(en)
*
|
2003-11-25 |
2005-05-26 |
Edwin Hirahara |
Method and system of manufacturing artificial seed coats
|
|
US20050108929A1
(en)
*
|
2003-11-25 |
2005-05-26 |
Edwin Hirahara |
Method and system for creating manufactured seeds
|
|
US7555865B2
(en)
*
|
2003-11-25 |
2009-07-07 |
Weyerhaeuser Nr Company |
Method and system of manufacturing artificial seed coats
|
|
CA2486289C
(en)
*
|
2003-11-25 |
2008-01-08 |
Weyerhaeuser Company |
Combination end seal and restraint
|
|
US7356965B2
(en)
*
|
2003-12-11 |
2008-04-15 |
Weyerhaeuser Co. |
Multi-embryo manufactured seed
|
|
US7591287B2
(en)
*
|
2003-12-18 |
2009-09-22 |
Weyerhaeuser Nr Company |
System and method for filling a seedcoat with a liquid to a selected level
|
|
US7568309B2
(en)
*
|
2004-06-30 |
2009-08-04 |
Weyerhaeuser Nr Company |
Method and system for producing manufactured seeds
|
|
EP1794586B1
(en)
|
2004-09-22 |
2013-01-30 |
Cancer Advances, Inc., |
Monoclonal antibodies to progastrin
|
|
CA2518166C
(en)
*
|
2004-09-27 |
2012-02-21 |
Weyerhaeuser Company |
Manufactured seed having a live end seal
|
|
CA2518279A1
(en)
*
|
2004-09-27 |
2006-03-27 |
Weyerhaeuser Company |
Manufactured seed having a live end seal coating
|
|
US7547488B2
(en)
*
|
2004-12-15 |
2009-06-16 |
Weyerhaeuser Nr Company |
Oriented strand board panel having improved strand alignment and a method for making the same
|
|
US7654037B2
(en)
*
|
2005-06-30 |
2010-02-02 |
Weyerhaeuser Nr Company |
Method to improve plant somatic embryo germination from manufactured seed
|
|
US8168592B2
(en)
|
2005-10-21 |
2012-05-01 |
Amgen Inc. |
CGRP peptide antagonists and conjugates
|
|
US8906857B2
(en)
*
|
2005-12-01 |
2014-12-09 |
B.R.A.H.M.S. Gmbh |
Methods for the diagnosis and treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists
|
|
JP4976412B2
(ja)
*
|
2005-12-01 |
2012-07-18 |
ベー・エル・アー・ハー・エム・エス・ゲーエムベーハー |
エンドセリン、エンドセリンアゴニスト及びアドレノメジュリンアンタゴニストによる危篤患者の診断及び治療のための方法
|
|
DE102006052916A1
(de)
*
|
2006-11-08 |
2008-05-15 |
Brahms Aktiengesellschaft |
Diagnose und Risikostratifizierung von Diabetes mellitus mittels MR-proADM
|
|
WO2009040027A1
(en)
*
|
2007-09-11 |
2009-04-02 |
Mondobiotech Laboratories Ag |
Use of the peptide stresscopin as a therapeutic agent
|
|
FR2934597B1
(fr)
*
|
2008-07-31 |
2013-04-19 |
Univ Aix Marseille Ii |
Anticorps se liant aux recepteurs de l'adrenomedulline et leurs utilisations comme medicament.
|
|
EP2356452B1
(en)
*
|
2008-10-31 |
2019-04-24 |
B.R.A.H.M.S GmbH |
Methods and assays for classifying foodstuff and/or beverage and/or diet and/or nutrition regimen and/or medicament in view of an effect on the cardiovascular system
|
|
CN108530543B
(zh)
|
2009-02-03 |
2023-06-23 |
阿穆尼克斯制药公司 |
延伸重组多肽和包含该延伸重组多肽的组合物
|
|
EP2389799A1
(en)
*
|
2010-05-25 |
2011-11-30 |
BioMass Booster, S.L. |
Method for increasing plant biomass
|
|
JP5684904B2
(ja)
*
|
2010-06-18 |
2015-03-18 |
セザンヌ ソシエテ パ アクシオンス シンプリフィエ |
妊娠高血圧症及び子癇前症の予後診断とリスクの評価のためのマーカー
|
|
FR2964103B1
(fr)
*
|
2010-08-30 |
2018-11-23 |
Universite D'aix-Marseille |
Anticorps se liant a l'adrenomedulline et aux recepteurs de l'adrenomedulline et leurs utilisations comme medicament
|
|
JP5932279B2
(ja)
*
|
2011-10-07 |
2016-06-08 |
ポーラ化成工業株式会社 |
スクリーニング方法
|
|
US8776012B2
(en)
*
|
2011-10-25 |
2014-07-08 |
International Business Machines Corporation |
Automatic scheduling of review meetings
|
|
SG11201402358RA
(en)
|
2011-11-16 |
2014-06-27 |
Adrenomed Ag |
Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizing the circulation
|
|
PT3553084T
(pt)
*
|
2011-11-16 |
2023-02-17 |
Adrenomed Ag |
Anticorpo anti-adrenomedulina (adm) ou fragmento de anticorpo anti-adm ou esqueleto não-ig anti-adm para prevenção ou redução de disfunção de órgãos ou insuficiência de órgãos num paciente possuindo uma doença crónica ou aguda ou condição aguda
|
|
SG11201402354YA
(en)
|
2011-11-16 |
2014-06-27 |
Adrenomed Ag |
Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for regulating the fluid balance in a patient having a chronic or acute disease
|
|
EP2780717B1
(en)
*
|
2011-11-16 |
2016-12-21 |
sphingotec GmbH |
Adrenomedullin assays and methods for determining mature adrenomedullin
|
|
JP5953108B2
(ja)
*
|
2012-05-14 |
2016-07-20 |
ポーラ化成工業株式会社 |
スクリーニング方法
|
|
WO2014054798A1
(ja)
|
2012-10-04 |
2014-04-10 |
独立行政法人国立循環器病研究センター |
悪性腫瘍転移抑制用医薬
|
|
EP3082858B1
(en)
|
2013-12-20 |
2021-01-27 |
AngioBiomed GmbH |
Adrenomedullin binder for use in therapy of cancer
|
|
PT3067093T
(pt)
*
|
2015-03-12 |
2019-11-18 |
Fund Rioja Salud |
Utilização de um inibidor de adrenomedulina para a produção de um fármaco útil na prevenção e tratamento de doenças que reduzem a densidade óssea
|
|
WO2018213934A1
(en)
|
2017-05-26 |
2018-11-29 |
The Governors Of The University Of Alberta |
Self-assembling peptide for activating human mast cells
|
|
KR102772810B1
(ko)
|
2017-06-15 |
2025-02-28 |
캔서 어드밴시스 아이엔씨 |
종양 및 암에 대한 체액성 및 세포 면역을 유도하기 위한 조성물 및 방법
|
|
US12150978B2
(en)
|
2017-06-15 |
2024-11-26 |
Cancer Advances Inc. |
Compositions and methods for preventing tumors and cancer
|
|
EP3438668A1
(en)
*
|
2017-08-04 |
2019-02-06 |
B.R.A.H.M.S GmbH |
Diagnosis and risk stratification of fungal infections
|
|
EP3971572A1
(en)
|
2017-09-13 |
2022-03-23 |
B.R.A.H.M.S GmbH |
Proadrenomedullin as a marker for abnormal platelet levels
|
|
EP3682246A1
(en)
|
2017-09-13 |
2020-07-22 |
B.R.A.H.M.S GmbH |
Method for guidance of fluid therapy based on proadrenomedullin
|
|
EP3502706A1
(en)
|
2017-12-20 |
2019-06-26 |
B.R.A.H.M.S GmbH |
Workflow for risk assessment and patient management using procalcitonin and midregional-proadrenomedullin
|
|
EP3578989A1
(en)
|
2018-06-06 |
2019-12-11 |
B.R.A.H.M.S GmbH |
Pro-adm for prognosis of trauma-related complications in polytrauma patients
|
|
IL292863A
(en)
|
2019-11-13 |
2022-07-01 |
Amunix Pharmaceuticals Inc |
Barcoded xanthan polypeptides and their compositions, and methods for their preparation and use
|